首页|抗肿瘤药效研究中疗效与安全性综合评价指标的选择

抗肿瘤药效研究中疗效与安全性综合评价指标的选择

扫码查看
目的 传统抗肿瘤药效评价指标中体质量、肿瘤体积和抑瘤率可以分别体现制剂的安全性和疗效,但是单一指标并不能兼顾这两点。为此,新的抗肿瘤药效评价指标被提出,其中抑瘤指数可以全面地呈现药物的治疗效果。方法 以表柔比星相关制剂的药效学实验数据为例,对"新"和"旧"抗肿瘤评价指标的统计结果进行分析。结果 聚乙二醇修饰脂质体组内小鼠的抑瘤率(0。80±0。05)与唾液酸修饰脂质体组内小鼠的抑瘤率(0。89±0。01)无显著性差异(P≥0。05),但是聚乙二醇修饰脂质体组内小鼠的抑瘤指数(40±9)显著低于唾液酸修饰脂质体组内小鼠的抑瘤指数(82±7,P<0。001)。结论 "新"抗肿瘤评价指标更适合用于抗肿瘤研究的数据分析。
Selection of comprehensive evaluation indexes for efficacy and safety in anti-tumor drug effect research
Objective Body mass,tumor volume,and tumor inhibition rate in traditional anti-tumor evaluation indicators can respectively reflect safety and efficacy of preparation.But a single indicator cannot consider both points.For this reason,a new evaluation index of anti-tumor drug efficacy has been proposed,among which the tumor inhibition index can comprehensively evaluate the efficacy of drug.Methods Taking the pharmacodynamic experiment data of epirubicin-related preparations as an example,we analyzed calculation results of"new"and"old"anti-tumor evaluation indexes.Results Tumor inhibition rate of mice in PEG-modified liposome group(0.80±0.05)was not significantly different from that of sialic acid-modified liposome group(0.89±0.01,P ≥0.05),but tumor inhibition index of mice in PEG-modified liposome group(40±9)was significantly lower than that of sialic acid-modified liposome group(82±7,P<0.001).Conclusion In this experiment found that"new"anti-tumor evaluation index is more suitable for data analysis of anti-tumor research.

tumor inhibition indextumor inhibition ratesafetyefficacy

隋德志、李长智、刘欣荣、邓意辉、宋艳志

展开 >

沈阳药科大学药学院,辽宁沈阳 110016

抑瘤指数 抑瘤率 安全性 疗效

国家自然科学基金沈阳药科大学中青年教师职业发展极化项目

81703456ZQN2021009

2024

沈阳药科大学学报
沈阳药科大学

沈阳药科大学学报

CSTPCD
影响因子:0.604
ISSN:1006-2858
年,卷(期):2024.41(2)
  • 22